| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,310 |
13,089 |
$1.09M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,961 |
11,921 |
$686K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,658 |
6,576 |
$194K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,522 |
2,508 |
$186K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,416 |
2,372 |
$159K |
| X5622 |
|
2,906 |
2,810 |
$111K |
| 99215 |
Prolong outpt/office vis |
845 |
816 |
$108K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,483 |
1,459 |
$107K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
783 |
755 |
$65K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,561 |
1,501 |
$50K |
| 36415 |
Collection of venous blood by venipuncture |
13,895 |
12,715 |
$50K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,569 |
1,511 |
$50K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
9,728 |
9,609 |
$33K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,283 |
1,272 |
$33K |
| 99188 |
|
3,549 |
3,534 |
$28K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
1,043 |
971 |
$26K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,168 |
1,158 |
$25K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,623 |
1,606 |
$25K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,271 |
2,226 |
$24K |
| 92551 |
|
3,804 |
3,764 |
$24K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,607 |
2,577 |
$23K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
335 |
329 |
$23K |
| 81514 |
|
84 |
83 |
$22K |
| 86780 |
|
1,710 |
1,686 |
$20K |
| 80061 |
Lipid panel |
1,529 |
1,511 |
$19K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
660 |
635 |
$16K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
176 |
173 |
$15K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
186 |
181 |
$14K |
| 90686 |
|
3,345 |
3,310 |
$14K |
| 90834 |
Psychotherapy, 45 minutes with patient |
189 |
147 |
$14K |
| 0002A |
|
419 |
418 |
$13K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
340 |
330 |
$12K |
| 87481 |
|
327 |
321 |
$11K |
| 0001A |
|
401 |
397 |
$11K |
| 85027 |
|
1,702 |
1,662 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,435 |
1,400 |
$10K |
| 90715 |
|
511 |
501 |
$9K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
327 |
318 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,164 |
1,141 |
$8K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
218 |
213 |
$8K |
| 87150 |
|
196 |
194 |
$7K |
| 81025 |
|
964 |
943 |
$7K |
| 97810 |
|
333 |
149 |
$7K |
| 87340 |
|
680 |
672 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,041 |
1,019 |
$6K |
| 76801 |
|
68 |
68 |
$6K |
| 86850 |
|
726 |
719 |
$6K |
| 86803 |
|
381 |
379 |
$6K |
| 91322 |
|
45 |
45 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
130 |
129 |
$5K |
| 99173 |
|
3,495 |
3,459 |
$5K |
| 80053 |
Comprehensive metabolic panel |
472 |
461 |
$5K |
| 97811 |
|
332 |
149 |
$5K |
| 86762 |
|
337 |
335 |
$4K |
| 90677 |
|
335 |
331 |
$4K |
| 87338 |
|
282 |
280 |
$4K |
| 82728 |
|
297 |
293 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
61 |
61 |
$4K |
| 85018 |
|
1,855 |
1,824 |
$4K |
| 90651 |
|
174 |
166 |
$4K |
| 87210 |
|
725 |
709 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
77 |
76 |
$3K |
| 97813 |
|
129 |
54 |
$3K |
| 84702 |
|
205 |
174 |
$3K |
| 0124A |
|
79 |
77 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
390 |
376 |
$3K |
| 86787 |
|
225 |
224 |
$3K |
| 83013 |
|
35 |
34 |
$3K |
| 81001 |
|
979 |
956 |
$3K |
| 82950 |
|
599 |
593 |
$3K |
| 97814 |
|
129 |
54 |
$3K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
218 |
217 |
$2K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
443 |
431 |
$2K |
| 0054A |
|
56 |
56 |
$2K |
| 90480 |
|
88 |
87 |
$2K |
| 83655 |
|
279 |
279 |
$2K |
| 36416 |
|
884 |
859 |
$2K |
| 99177 |
|
596 |
591 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
107 |
107 |
$2K |
| 59025 |
Fetal non-stress test |
107 |
86 |
$2K |
| 0071A |
|
43 |
41 |
$2K |
| 82607 |
|
114 |
112 |
$2K |
| 87081 |
|
493 |
476 |
$2K |
| 90837 |
Psychotherapy, 53 minutes with patient |
18 |
12 |
$1K |
| 96127 |
|
378 |
370 |
$1K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
17 |
17 |
$1K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
12 |
12 |
$1K |
| 0072A |
|
31 |
31 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
181 |
179 |
$1K |
| 0052A |
|
27 |
27 |
$1K |
| 86900 |
|
405 |
400 |
$1K |
| 86901 |
|
405 |
400 |
$1K |
| 90656 |
|
167 |
167 |
$1K |
| 0004A |
|
49 |
45 |
$991.38 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
13 |
$966.63 |
| 0051A |
|
22 |
22 |
$867.00 |
| 90670 |
|
1,598 |
1,579 |
$774.87 |
| 90832 |
Psychotherapy, 30 minutes with patient |
15 |
15 |
$767.26 |
| 90716 |
|
550 |
547 |
$626.07 |
| 83540 |
|
55 |
53 |
$363.39 |
| 90688 |
|
114 |
112 |
$334.30 |
| 83014 |
|
35 |
34 |
$312.72 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
40 |
37 |
$269.73 |
| 83550 |
|
28 |
28 |
$262.62 |
| G0008 |
Administration of influenza virus vaccine |
27 |
27 |
$245.20 |
| 84439 |
|
24 |
24 |
$227.69 |
| 82565 |
|
39 |
38 |
$206.38 |
| 96380 |
|
14 |
14 |
$194.44 |
| 81003 |
|
131 |
129 |
$183.31 |
| 90707 |
|
222 |
221 |
$175.12 |
| 84450 |
|
29 |
27 |
$146.59 |
| 90633 |
|
609 |
606 |
$6.40 |
| 90681 |
|
266 |
264 |
$0.00 |
| 90700 |
|
24 |
24 |
$0.00 |
| 90734 |
|
43 |
42 |
$0.00 |
| 83020 |
|
17 |
17 |
$0.00 |
| 90723 |
|
1,468 |
1,453 |
$0.00 |
| 90647 |
|
1,215 |
1,200 |
$0.00 |
| 98941 |
Chiropractic manipulative treatment; spinal, 3-4 regions |
48 |
26 |
$0.00 |
| 90696 |
|
65 |
65 |
$0.00 |
| 83021 |
|
17 |
17 |
$0.00 |
| 90694 |
|
15 |
14 |
$0.00 |